
Asthma/COPD drug PMPM spending U.S. 2019-2024
In 2024, per member per month (PMPM) spending for asthma and COPD (chronic obstructive pulmonary disease) prescription drug is forecasted to be around 2.35 U.S. dollars per member per month in the United States. This statistic illustrates the forecast of asthma prescription drug PMPM spending in the United States from 2019 to 2024.